Study to Evaluate the Safety and How the Body Handles a Single Dose of Subcutaneous (SC) and Intravenous (IV) Budigalimab in Adult Participants Living With Human Immunodeficiency Virus (HIV)
Clinical trial NCT04799353 · COMPLETED
Trial details
- NCT number
- NCT04799353
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-15
- Primary completion
- 2022-10-11
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.